Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.967,21
0,04%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC IntelliPharmaCeutics International Inc (QB) (IPCIF) IntelliPharmaCeutics International Inc (QB) (IPCIF) Notizie

IPCIF

IntelliPharmaCeutics (QB) (IPCIF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:IPCIF
DataOraFonteTitoloSimboloCompagnia
07/03/202421:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
14/02/202420:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
21/07/202223:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
15/02/202212:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
31/03/202123:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
16/02/202123:36Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
15/07/202023:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
07/01/202020:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
18/11/201923:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
03/06/201916:00Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
04/03/201913:07Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
28/11/201813:00InvestorsHub NewsWireGD Entertainment and Technology (GDET) Benefit from the transactional side of BitcoinUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
15/10/201813:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
12/10/201812:08Edgar (US Regulatory)Registration of Additional Securities (up to 20%, Foreign Issuer) (f-1mef)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
12/10/201812:07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
11/10/201812:42Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
05/10/201823:43Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
20/09/201823:37Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
24/07/201823:25Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
03/04/201823:13Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
20/03/201811:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
24/01/201814:00GlobeNewswire Inc.Intellipharmaceutics Provides Operational UpdateUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
05/12/201714:00GlobeNewswire Inc.Intellipharmaceutics Announces Receipt of Nasdaq NoticeUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
30/11/201716:45GlobeNewswire Inc.Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par PharmaceuticalUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
13/10/201723:45GlobeNewswire Inc.Intellipharmaceutics Announces Closing of US$4 Million FinancingUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
11/10/201714:00GlobeNewswire Inc.Intellipharmaceutics Announces US$4 Million Registered Direct OfferingUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
10/10/201723:20GlobeNewswire Inc.Intellipharmaceutics Announces Third Quarter 2017 ResultsUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
25/09/201713:00GlobeNewswire Inc.Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDAUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
01/09/201714:00GlobeNewswire Inc.Intellipharmaceutics Appoints New Chief Financial OfficerUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
08/08/201721:00GlobeNewswire Inc.Intellipharmaceutics Announces Resignation of Chief Financial OfficerUSOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:IPCIF

La tua Cronologia

NYSE
WRB-G
WR Berkley
USOTC
SDSS
Suspect Detection Systems (CE)
COIN
BCHAKRW
LSE
0J2S
Ast Groupe
LSE
0JPK
DOWI
GLXY
ASX
MGRKOQ
COIN
FLOKICEOUST
FLOKI CEO
NASDAQ
MDIA
Mediaco
EU
IEPAB
LYXOR EPAB INAV
DBI
0J00
INAV DBX MSCI USA CHF
TSXV
DHB.WT
Delivra Health Brands
USOTC
KHOTF
Kahoot ASA (PK)
BIT
I07882
Intesa Sanpaolo
NASDAQ
AAXZEXX
Jpmorgan Chase Bank Na P...
NASDAQ
AAXRDXX
JPMorgan Chase Financial...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network